ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease

Ann Oncol. 2005:16 Suppl 1:i54-5. doi: 10.1093/annonc/mdi814.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Dacarbazine / administration & dosage
  • Diagnosis, Differential
  • Doxorubicin / administration & dosage
  • Hodgkin Disease / diagnosis*
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / pathology
  • Humans
  • Incidence
  • Neoplasm Staging
  • Recurrence
  • Risk Assessment
  • Vinblastine / administration & dosage

Substances

  • Bleomycin
  • Vinblastine
  • Dacarbazine
  • Doxorubicin

Supplementary concepts

  • ABVD protocol